AbbVie | ABBV - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

AbbVie

AbbVie reported $3.97B in Cost of Sales for its fiscal quarter ending in March of 2023.


Cost Of Sales Change
AbbVie ABBV:US USD 3.97B 200M
Abbott ABT:US USD 4.32B 209M
ALKERMES ALKS:US USD 58.18M 4.21M
Amgen AMGN:US USD 1.68B 65M
AstraZeneca AZN:LN USD 2.05B 458M
Biogen BIIB:US USD 662.8M 91.9M
BioMarin Pharmaceutical BMRN:US USD 126.55M 741K
Bristol-Myers Squibb BMY:US USD 2.56B 45M
Coherus Biosciences CHRS:US USD 16.87M 2.67M
Eisai 4523:JP JPY 38.57B 8.17B
Eli Lilly LLY:US USD 1.63B 78.6M
Endo International ENDP:US USD 167.44M 51.37M
Gilead Sciences GILD:US USD 1.4B 5M
GlaxoSmithKline GSK:LN GBP 1.9B 274M
Horizon Pharma HZNP:US USD 208.56M 32.22M
Infinity Pharmaceuticals INFI:US USD 441K 114K
Intercept Pharmaceuticals ICPT:US USD 222K 194K
J&J JNJ:US USD 8.4B 684M
Merck & Co MRK:US USD 3.35B 491M
Neurocrine Biosciences NBIX:US USD 8.5M 800K
Novartis NOVN:VX USD 3.83B 8M
Pacira PCRX:US USD 49.02M 12.9M
Perrigo PRGO:US USD 767.9M 4.8M
Pfizer PFE:US USD 5.03B 4.8B
Regeneron Pharmaceuticals REGN:US USD 457.5M 83.1M
Revance Therapeutics RVNC:US USD 16.17M 7.34M
Roche Holding ROG:VX CHF 8.95B 613M
UCB UCB:BB EUR 829M 16M
Ultragenyx Pharmaceutical RARE:US USD 12.26M 6.94M
United Therapeutics UTHR:US USD 52.3M 6.5M
Vertex Pharmaceuticals VRTX:US USD 266.9M 16.4M
Zoetis ZTS:US USD 554M 97M